Personal Finance on Yik Yak | Check out $AQST before it’s too late. In the next roughly 20 days their allergy med anaphylm (aqst-109) should be accepted. It’s an epi-pen alternative oral strip. Their patented film is interesting enough on its own. Much better than nasal

Yik Yak

Download

Join communities on Yik Yak Download

Personal Finance 17w

Check out $AQST before it’s too late. In the next roughly 20 days their allergy med anaphylm (aqst-109) should be accepted. It’s an epi-pen alternative oral strip. Their patented film is interesting enough on its own. Much better than nasal

Anonymous 17w

Been tracking it for several years. Here’s my total accumulation. I have collected profits several times over the years. Very strongly believe in this company

Anonymous

OP 17w

Invested in a company similar to this. The stock lost 50% in one day. Just invest in the s&p and chill. No need for this risk

Anonymous

#1 17w

Ive been in biotech space for years. Yea it’s higher risk but this drug is literally weeks away from approval and unlike most small cap bios the company has existing products. Epinephrine market is expected to hit 4.5 billion by 2030. Only competition in the space is a significantly less effective nasal spray and the existing epi-pen.